KALA BIO, Inc. (KALA) Insider Trading Disclosures
KALA BIO, Inc. (KALA) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: KALA
CIK: 1479419
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
HTL International, LLC
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerYongmei Huang
Audit LocationHouston, Texas, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| DEF 14A | 2026-09-24 | 2026-11-03 | DEF 14A | 0001829126-26-010384 | View SEC Doc Filr Page |
| PRE 14A | 2026-09-11 | 2026-09-11 | PRE 14A | 0001829126-26-010053 | View SEC Doc Filr Page |
| 8-K | 2026-09-10 | 2026-09-03 | 8-K | 0001829126-26-009999 | View SEC Doc Filr Page |
| 8-K | 2026-09-09 | 2026-09-09 | 8-K | 0001829126-26-009946 | View SEC Doc Filr Page |
| 8-K | 2026-08-28 | 2026-08-27 | 8-K | 0001829126-26-009454 | View SEC Doc Filr Page |
| 10-Q | 2026-08-19 | 2026-06-30 | 10-Q | 0001104659-26-098783 | View SEC Doc Filr Page |
| NT 10-Q | 2026-08-14 | 2026-06-30 | NT 10-Q | 0001829126-26-008832 | View SEC Doc Filr Page |
| 8-K | 2026-07-23 | 2026-07-22 | 8-K | 0001829126-26-007760 | View SEC Doc Filr Page |
| 424B5 | 2026-07-22 | — | 424B5 | 0001829126-26-007754 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-07-02 | — | SCHEDULE 13D/A Filing | 0001829126-26-007224 | View SEC Doc Filr Page |
| EFFECT | 2026-06-25 | — | EFFECT Filing | 9999999995-26-002122 | View SEC Doc Filr Page |
| S-3/A | 2026-06-12 | — | S-3/A | 0001829126-26-006442 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001104659-26-062584 | View SEC Doc Filr Page |
| 10-Q | 2026-05-15 | 2026-03-31 | 10-Q | 0001104659-26-062397 | View SEC Doc Filr Page |
| S-3 | 2026-05-07 | — | S-3 | 0001829126-26-004790 | View SEC Doc Filr Page |
| 8-K | 2026-05-07 | 2026-05-07 | 8-K | 0001829126-26-004744 | View SEC Doc Filr Page |
| 10-K | 2026-04-15 | 2025-12-31 | 10-K | 0001104659-26-043782 | View SEC Doc Filr Page |
| NT 10-K | 2026-03-31 | 2025-12-31 | NT 10-K | 0001829126-26-002931 | View SEC Doc Filr Page |
| D | 2026-03-17 | — | D Filing | 0001829126-26-002408 | View SEC Doc Filr Page |
| 144 | 2026-03-17 | — | 144 Filing | 0001950047-26-002718 | View SEC Doc Filr Page |
| 144 | 2026-03-12 | — | 144 Filing | 0001950047-26-002562 | View SEC Doc Filr Page |
| 144 | 2026-03-12 | — | 144 Filing | 0001950047-26-002513 | View SEC Doc Filr Page |
| 8-K | 2026-03-04 | 2026-03-03 | 8-K | 0001829126-26-001911 | View SEC Doc Filr Page |
| 8-K | 2026-02-20 | 2026-02-16 | 8-K | 0001829126-26-001534 | View SEC Doc Filr Page |
| EFFECT | 2026-02-17 | — | EFFECT Filing | 9999999995-26-000615 | View SEC Doc Filr Page |